Bulletin Venus Remedies Receives Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility Venus Remedies is thrilled to announce a major achievement: our pre-filled syringe (PFS) manufacturing unit in Baddi has been awarded the prestigious PIC/S GMP certification by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA). This is the first time our PFS facility has received accreditation under the Pharmaceutical Inspection Co-operation
Bulletin Breaking Barriers with Epigenetics in the Fight Against AMR We are delighted to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre, has authored a compelling article published in Hindustan Times E-Paper. This insightful piece, titled "Opening Frontiers with Epigenetics in Battle Against AMR," sheds light on
Bulletin Venus Remedies Leads Conversations on Breakthrough Diagnostic Technologies In alignment with Venus Remedies’ commitment to driving innovation in healthcare, our President of Global Critical Care, Mr. Saransh Chaudhary, recently shared valuable insights with India Pharma Outlook. In this engaging interview, Mr. Chaudhary discussed the critical areas of sepsis and antimicrobial resistance (AMR), illuminating how innovations in diagnostics and
Events Venus Remedies Shaping Healthcare at CPhI Milan 2024 Milan, Italy – 8-10 October 2024 Venus Remedies was once again thrilled to be a part of CPhI this year, a significant global event for the pharmaceutical industry held in the stunning city of Milan. This event brought together key industry leaders from across the globe, highlighting the importance of innovation,
Accreditations & Approvals Venus Remedies Secures Key Approvals in Multiple Markets Pharma major Venus Remedies Limited has recently made significant progress in its global expansion by obtaining marketing approvals (MAs) for a wide range of drugs in different countries. We’re excited to share that Carboplatin and Carbol have been approved in Morocco, along with Bortezomib, Gemcitabine, Cefepime, and Oxaliplatin in
Bulletin Venus Showcases Key Brands at ROSA CON 2024 Venus recently participated in the prestigious ROSA CON 2024, a zonal conference focusing on orthopedic specialties held in Bikaner. This event gathered leading orthopedic professionals and industry experts, providing a vital platform for sharing knowledge and advancing practices in the field. During the conference, Venus proudly showcased its prominent brands:
Bulletin Venus Remedies Joins AMR Vivli to Combat Antimicrobial Resistance Venus Remedies is proud to announce its official membership in AMR Vivli, a global platform dedicated to sharing critical data on antimicrobial resistance (AMR). Supported by the Wellcome Trust, AMR Vivli provides a crucial platform for researchers, healthcare organizations, and industry leaders to collaborate in combating AMR, which has become
Publications R3SET's Innovative Wellness Products Spotlighted in Harper's Bazaar R3SET, our brand dedicated to enhancing daily wellness rituals through innovative and sustainable solutions, has been featured in the prestigious Harper's Bazaar magazine. The two-page article in the July 2024 edition, found on pages 78 and 79, highlights our unique approach and extensive product range that cater to a variety
Awards Venus Remedies Honored with Excellence in Governance & Statutory Compliance Award Venus Remedies Limited has been honored with the prestigious Excellence in Governance & Statutory Compliance Award by the PHD Chamber of Commerce, Chandigarh, at the HR Conclave 2024. This esteemed recognition underscores our unwavering commitment to achieving the highest standards in governance and statutory compliance. A Testament to Our Commitment Out
Events Venus Remedies Hosts Comprehensive CMEs Across Multiple Locations In a concerted effort to enhance medical education and address critical healthcare challenges, Venus Remedies organized a series of Continuing Medical Education (CME) sessions throughout June 2024. These CMEs, held across various locations, focused on the pressing issue of antimicrobial resistance (AMR) and other critical medical topics. The sessions were
Accreditations & Approvals Venus Remedies Secures Major Tenders from UNICEF and PAHO to Enhance Global Healthcare Venus Remedies Limited, a global leader in the pharmaceutical industry, has achieved significant milestones by securing two prestigious tenders from globally renowned organizations—UNICEF and the Pan American Health Organization (PAHO). These wins mark a pivotal moment in the company's journey towards enhancing healthcare access and outcomes worldwide. UNICEF Tender
Accreditations & Approvals Venus Remedies Secures Registrations for its Unit-2 in Baddi and Venus Pharma GmbH from Kuwait Venus Remedies Limited is delighted to announce the successful registration of our Unit-2 in Baddi and Venus Pharma GmbH from Kuwait, alongside obtaining Marketing Authorizations (MAs) for Carboplatin 450 MG/45 ML. These achievements mark significant milestones in our ongoing commitment to expanding our global footprint and enhancing our pharmaceutical
Publications There’s a Pressing Need to Implement Antibiotic Protocol in All Hospitals We are pleased to share that an insightful article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been featured in the renowned publication Down To Earth. The article, titled "There’s a Pressing Need to Implement Antibiotic Protocol in All Hospitals,
Publications Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on Superbugs We are thrilled to announce that an article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been prominently featured in Pharma Focus Asia. The article, titled "Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on
Publications Featured Article on IP Laws and Generic Manufacturing Featured in ET Healthworld We are delighted to announce that an article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been prominently featured in ET Healthworld on the occasion of World Intellectual Property Day. The article, titled "Balancing IP Laws and Generic Manufacturing to Propel,
Accreditations & Approvals Featured Venus Remedies Secures Coveted UNICEF Approval for Global Impact Venus Remedies Limited, a leading pharmaceutical company with a global footprint, is proud to announce its recent attainment of Good Manufacturing Practices (GMP) approval from the United Nations Children's Fund (UNICEF). This approval signifies a significant milestone for the company, highlighting its unwavering commitment to delivering top-tier pharmaceutical solutions worldwide.
Accreditations & Approvals Featured Empowering Innovation: Venus Remedies Receives Incentive under Government's PLI Scheme In a testament to its commitment to innovation and growth, Venus Remedies Limited proudly announces its successful acquisition of an incentive under the Government of India's Production Linked Incentive (PLI) scheme. The company has secured a substantial incentive amounting to ₹7.5 crore, representing 75% of the total incentive for
Corporate Social Responsibility Featured Empowering Minds: Venus Remedies' Journey to Smarten Up Panchkula's School In a remarkable stride towards fostering education and community development, Venus Remedies has embarked on a noble initiative by adopting a government school in Panchkula. With an unwavering commitment to uplift the educational standards and provide modern facilities, Venus Remedies has resolved to transform the school into a 'smart' institution.
Publications Featured Pharma's Call for Innovation and Policy Support in Budget 2024 As we approach Budget 2024-2025, the pharmaceutical industry eagerly awaits pivotal decisions that will shape India's trajectory towards becoming the 'Pharmacy to the World' and embracing 'OneHealth' principles. Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre (VMRC), recently shared
Accreditations & Approvals Featured Venus Remedies Attains GMP Certification from Libya, Amplifying its Presence in Africa's Pharmaceutical Landscape Venus Remedies has recently been awarded the prestigious Good Manufacturing Practices (GMP) certification by Libya. This certification is a testament to Venus Remedies' unwavering commitment to maintaining the highest standards of quality and safety in the pharmaceutical industry. The GMP certification from Libya reflects Venus Remedies' adherence to stringent guidelines
The Grand Launch Venus Remedies Launches Hepa-20 in Nepal: A Breakthrough in Liver Care Venus Remedies Limited is proud to announce the launch of Hepa-20, a new and innovative liver care product, in Nepal. This milestone marks a significant step in our commitment to enhancing healthcare and addressing liver health issues in the region. Understanding Hepa-20 Hepa-20 is formulated with the latest advancements in
Awards Featured Third Time's a Charm!! Celebrating Excellence: Venus Remedies Secures Great Place to Work Certification for the Third Consecutive Year! Venus Remedies has once again achieved the prestigious Great Place to Work (GPTW) certification for the third consecutive year! As a company committed to cultivating an inclusive and positive workplace culture, this award is truly
Accreditations & Approvals Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines Venus Remedies Limited recently obtained regulatory approval for the marketing of three essential drugs in Saudi Arabia and the Philippines. In the dynamic region of Asia, Venus Remedies has received approval for Paclitaxel 100mg/16.7ml and Zoledronic Acid 4mg in the Philippines. These medications are crucial components in the
Accreditations & Approvals Featured Venus Remedies Breaks New Ground with Marketing Authorization for Enoxaparin in Azerbaijan Venus Remedies Limited, a pioneer in fixed-dosage injectable manufacturing, is proud to announce a major stride in its global expansion strategy. The company has achieved marketing authorization for Enoxaparin in Azerbaijan, marking its entry into this dynamic pharmaceutical market for the first time. Enoxaparin, a vital anticoagulant, plays a pivotal
Accreditations & Approvals Venus Remedies Attains the Coveted 'Three Star Export House' Certification from the Government of India! Venus Remedies, a trailblazing pharmaceutical company, has achieved the prestigious 'Three Star Export House' certification from the Government of India, Ministry of Commerce and Industry, Directorate General of Foreign Trade. This remarkable accomplishment underscores Venus Remedies' unwavering commitment to excellence in international trade and its dedication to global health. From
